BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 25476465)

  • 21. Bile duct angulation and tumor vascularity are useful radiographic features for differentiating pancreatic head cancer and intrapancreatic bile duct cancer.
    Kohga A; Yamamoto Y; Sugiura T; Okamura Y; Ito T; Ashida R; Aramaki T; Sasaki K; Uesaka K
    Surg Today; 2018 Jul; 48(7):673-679. PubMed ID: 29460125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pattern of lymph node involvement and prognosis in pancreatic adenocarcinoma: direct lymph node invasion has similar survival to node-negative disease.
    Pai RK; Beck AH; Mitchem J; Linehan DC; Chang DT; Norton JA; Pai RK
    Am J Surg Pathol; 2011 Feb; 35(2):228-34. PubMed ID: 21263243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgical treatment of intraductal papillary-mucinous tumor (IPMT) of the pancreas: operative indications based on surgico-pathologic study focusing on invasive carcinoma derived from IPMT.
    Seki M; Yanagisawa A; Ohta H; Ninomiya Y; Sakamoto Y; Yamamoto J; Yamaguchi T; Ninomiya E; Takano K; Aruga A; Yamada K; Sasaki K; Kato Y
    J Hepatobiliary Pancreat Surg; 2003; 10(2):147-55. PubMed ID: 14505148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation between radiographic classification and pathological grade of portal vein wall invasion in pancreatic head cancer.
    Nakao A; Kanzaki A; Fujii T; Kodera Y; Yamada S; Sugimoto H; Nomoto S; Nakamura S; Morita S; Takeda S
    Ann Surg; 2012 Jan; 255(1):103-8. PubMed ID: 22156923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recurrence and Survival After Resection of Small Intraductal Papillary Mucinous Neoplasm-associated Carcinomas (≤20-mm Invasive Component): A Multi-institutional Analysis.
    Winter JM; Jiang W; Basturk O; Mino-Kenudson M; Fong ZV; Tan WP; Lavu H; Vollmer CM; Furth EE; Haviland D; Klimstra DS; Jarnagin WR; Lillemoe KD; Yeo CJ; Fernandez-Del Castillo C; Allen PJ
    Ann Surg; 2016 Apr; 263(4):793-801. PubMed ID: 26135696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical implication of morphological subtypes in management of intraductal papillary mucinous neoplasm.
    Yamada S; Fujii T; Shimoyama Y; Kanda M; Nakayama G; Sugimoto H; Koike M; Nomoto S; Fujiwara M; Nakao A; Kodera Y
    Ann Surg Oncol; 2014 Jul; 21(7):2444-52. PubMed ID: 24562937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathomorphologic study of undifferentiated carcinoma in seven cases: relationship between tumor and pancreatic duct epithelium.
    Naito Y; Kinoshita H; Okabe Y; Arikawa S; Higaki K; Morimitsu Y; Yamasaki F; Suda K; Yasumoto M; Kusano H; Nakashima O; Yano H
    J Hepatobiliary Pancreat Surg; 2009; 16(4):478-84. PubMed ID: 19367361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation between CT patterns and pathological classification of intraductal papillary mucinous neoplasm.
    Zhang J; Wang PJ; Yuan XD
    Eur J Radiol; 2010 Jan; 73(1):96-101. PubMed ID: 19008065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Well differentiation and intact Smad4 expression are specific features of groove pancreatic ductal adenocarcinomas.
    Izumi S; Nakamura S; Mano S; Akaki S
    Pancreas; 2015 Apr; 44(3):394-400. PubMed ID: 25426619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survival among pancreaticoduodenectomy patients treated for pancreatic head cancer <1 or 2 cm.
    Franko J; Hugec V; Lopes TL; Goldman CD
    Ann Surg Oncol; 2013 Feb; 20(2):357-61. PubMed ID: 22941171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequential progression and intraductal spread of invasive ductal adenocarcinoma of the pancreas arising from around the main pancreatic duct.
    Tajiri T; Tate G; Ohike N; Kunimura T; Mitsuya T; Morohoshi T
    Hepatogastroenterology; 2005; 52(63):745-8. PubMed ID: 15966196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of pancreatic cancers during long-term follow-up of side-branch intraductal papillary mucinous neoplasms.
    Sawai Y; Yamao K; Bhatia V; Chiba T; Mizuno N; Sawaki A; Takahashi K; Tajika M; Shimizu Y; Yatabe Y; Yanagisawa A
    Endoscopy; 2010 Dec; 42(12):1077-84. PubMed ID: 21120776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of histologic subtype and growth pattern in intraductal papillary-mucinous carcinoma of the pancreas.
    Sanada Y; Kunita S; Yoshida K
    Oncol Rep; 2008 Jun; 19(6):1435-43. PubMed ID: 18497948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intraductal papillary components in invasive ductal carcinoma of the pancreas are associated with long-term survival of patients.
    Fukushima N; Sakamoto M; Mukai K; Kanai Y; Shimada K; Kosuge T; Hirohashi S
    Hum Pathol; 2001 Aug; 32(8):834-41. PubMed ID: 11521228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oncocytic-type intraductal papillary mucinous neoplasms: a unique malignant pancreatic tumor with good long-term prognosis.
    Marchegiani G; Mino-Kenudson M; Ferrone CR; Warshaw AL; Lillemoe KD; Fernández-del Castillo C
    J Am Coll Surg; 2015 May; 220(5):839-44. PubMed ID: 25840549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Invasive carcinoma originating in an intraductal papillary mucinous neoplasm of the pancreas: a clinicopathologic comparison with a common type of invasive ductal carcinoma.
    Shimada K; Sakamoto Y; Sano T; Kosuge T; Hiraoka N
    Pancreas; 2006 Apr; 32(3):281-7. PubMed ID: 16628084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgical and oncological impact of main pancreatic duct spread in invasive ductal adenocarcinoma: A clinicopathological study of 184 resected cases.
    Ishii M; Kimura Y; Sugita S; Imamura M; Ito T; Nobuoka T; Meguro M; Hasegawa T; Mizuguchi T; Hirata K
    Pancreatology; 2015; 15(6):681-7. PubMed ID: 26520652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intraductal papillary-mucinous neoplasms of the gastric and intestinal types may have less malignant potential than the pancreatobiliary type.
    Takasu N; Kimura W; Moriya T; Hirai I; Takeshita A; Kamio Y; Nomura T
    Pancreas; 2010 Jul; 39(5):604-10. PubMed ID: 20124938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heterogeneic distribution of thymidine phosphorylase between primary tumors and metastatic lesions of human pancreatic ductal carcinoma: implications for the efficacy of chemotherapy with 5-FU or its derivatives.
    Minari Y; Nio Y; Hirahara N; Dong M
    Cancer Chemother Pharmacol; 2001 May; 47(5):415-22. PubMed ID: 11391857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences between solid and duct-ectatic types of pancreatic ductal carcinomas.
    Furuta K; Watanabe H; Ikeda S
    Cancer; 1992 Mar; 69(6):1327-33. PubMed ID: 1540869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.